According to the update slides, the phase 1b/2 trial for mTNBC only had 3 patients enrolled and only 3 screened. THREE! The compassionate use trial has 14 enrolled and 66 screened. This makes no sense as there are 6 sites and I don’t want to hear that COVID19 is the cause as the basket trial, which started earlier this year, has 11 patients enrolled and 70 screened.

Also, the slide tells us that they need 5 patients from the phase 1B/2 trial on treatment for 6 months to submit for BTD. They have 1.

Cancer is going a lot slower than expected.